Poisoning & Drug
Poisoning & Drug
Poisoning & Drug
Objectives
• ABC
• Vital signs, mental status, and pupil size
• Pulse oximetry, cardiac monitoring, ECG
• Protect airway
• Intravenous access
• cervical immobilization if suspect trauma
• Rule out hypoglycemia
• Naloxone for suspected opiate poisoning
History
• Pill bottles
• Alcohol
• Drug history including access
• Remember OTC drugs
• Suicide note
• National Poisons Information Centre *
Examination
• Physiologic excitation –
anticholinergic, sympathomimetic, or central
hallucinogenic agents, drug withdrawal
• Physiologic depression –
cholinergic (parasympathomimetic), sympatholytic,
opiate, or sedative-hypnotic agents, or alcohols
• Mixed state –
polydrugs, hypoglycemic agents, tricyclic
antidepressants, salicylates, cyanide
Preventing Absorption
Gastric lavage
• Not in an unconscious patient unless intubated (risk aspiration)
• Flexible tube is inserted through the nose into the stomach
• Stomach contents are then suctioned via the tube
• A solution of saline is injected into the tube
• Recommended for up to 2 hrs in TCA & up to 4hrs in Salicylate
OD
Induced Vomiting
• Not routinely recommended
• Risk of aspiration
Preventing Absorption
Activated charcoal
• Adsorbs toxic substances or irritants, thus inhibiting GI
absorption
• Addition of sorbitol →laxative effect
• Oral: 25-100 g as a single dose
• repetitive doses useful to enhance the elimination of certain
drugs (eg, theophylline, phenobarbital, carbamazepine, aspirin,
sustained-release products)
• not effective for cyanide, mineral acids, caustic alkalis, organic
solvents, iron, ethanol, methanol poisoning, lithium
Elimination of Poisons
Renal elimination
• Medication to stimulate urination or defecation may be given to try to flush the
excess drug out of the body faster.
Forced alkaline diuresis
• Infusion of a large amount of NS+NAHCO3
• Used to eliminate acidic drugs that are mainly excreted by the kidney eg
salicylates
• Serious fluid and electrolytes disturbance may occur
• Need expert monitoring
Hemodialysis:
• Reserved for severe poisoning
• Drug should be dialyzable i.e. protein bound with a low volume of distribution
• may also be used temporarily or as long term if the kidneys are damaged due to
the overdose.
Antidotes
• Antidote – naloxone
• MOA: Pure opioid antagonist competes and displaces
narcotics at opioid receptor sites
• I.V. (preferred), I.M., intratracheal, SubQ: 0.4-2 mg every 2-3
minutes as needed
• Lower doses in opiate dependence
• Elimination half-life of naloxone is only 60 to 90 minutes
• Repeated administration/infusion may be necessary
• S/E BP changes; arrhythmias; seizures; withdrawal
Benzodiazepines
• Antidote – flumazenil
• MOA: Benzodiazepine antagonist
• IV administration 0.2 mg over 15 sec to max 3mg
• S/E N&V; arrhythmias; convulsions
• C/I concomitant TCAD; status epilepticus
• Should not be used for making the diagnosis
• Benzodiazepines may be masking/protecting against
other drug effects
TCAD Overdose -Treatment
1. Center for Behavioral Health Statistics and Quality. 2014 National Survey on Drug Use and Health: Detailed
Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015.
2. Translational research focus of NIDA organizational shift [news release]. Rockville MD: National Institute on Drug
Abuse; October 1, 2015.
https://archives.nida.nih.gov/news-events/news-releases/2015/10/translational-research-focus-of-nida-organizational-shi
ft
. Accessed September 24, 2015.
3. U.S. Department of Justice National Drug Intelligence Center. National Drug Threat Assessment 2011.
http://www.justice.gov/archive/ndic/pubs44/44849/44849p.pdf. Published August 2011. Accessed September 24, 2015.
4. U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report
of the Surgeon General. http://www.surgeongeneral.gov/library/reports/50-years-of-progress/full-report.pdf. Revised
January 2014. Accessed September 24, 2015.
5. Volkow ND, Baler RD. Addiction science: Uncovering neurobiological complexity. Neuropharmacology. 2014;76:235-
249.
6. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA
endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816-821.
7. HIPAA administrative simplification: enforcement. Office of the Secretary, HHS. Federal Register, Rules and
Regulations, Vol. 74. No.29; October 30, 2009. http://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/administrative/
enforcementrule/enfifr.pdf. Accessed September 24, 2015.